Hypha Laboratories Reveals New Patent Applications for Novel A.I. Driven In-Home Mycelium Production
Hypha Labs (OTCQB:FUNI) has filed new patent applications with the USPTO for novel AI-driven methods and devices for in-home mycelium production. The company aims to introduce the first consumer device for producing high-quality functional mushroom ingredients in an 8-day grow cycle, offering greater potency precision than commonly sold mushrooms at a fraction of current market prices.
The patents cover sophisticated machine learning algorithms for processing mycelium, addressing challenges in traditional cultivation methods. This innovation promises optimized growth conditions, faster processing times, enhanced yield predictability, and reduced resource consumption. The U.S. functional and psychedelic mushroom market reached $3.6 billion in 2022, with an expected CAGR of 12.1% from 2023 to 2030.
Hypha Labs (OTCQB:FUNI) ha presentato nuove domande di brevetto presso l'USPTO per metodi e dispositivi innovativi basati sull'IA per la produzione di micelio a casa. L'azienda mira a introdurre il primo dispositivo per consumatori per la produzione di ingredienti di funghi funzionali di alta qualità in un ciclo di crescita di 8 giorni, offrendo una maggiore precisione nella potenza rispetto ai funghi comunemente venduti, a una frazione dei prezzi di mercato attuali.
I brevetti coprono algoritmi di apprendimento automatico sofisticati per il processamento del micelio, affrontando le sfide dei metodi di coltivazione tradizionali. Questa innovazione promette condizioni di crescita ottimizzate, tempi di lavorazione più rapidi, una maggiore prevedibilità del raccolto e un consumo ridotto di risorse. Il mercato statunitense dei funghi funzionali e psichedelici ha raggiunto 3,6 miliardi di dollari nel 2022, con un CAGR previsto del 12,1% dal 2023 al 2030.
Hypha Labs (OTCQB:FUNI) ha presentado nuevas solicitudes de patente ante la USPTO para métodos y dispositivos innovadores impulsados por IA para la producción de micelio en casa. La empresa tiene como objetivo introducir el primer dispositivo para consumidores destinado a producir ingredientes de setas funcionales de alta calidad en un ciclo de crecimiento de 8 días, ofreciendo una mayor precisión en la potencia que los hongos comúnmente vendidos, a una fracción de los precios actuales del mercado.
Las patentes cubren algoritmos de aprendizaje automático sofisticados para el procesamiento de micelio, abordando desafíos en los métodos de cultivo tradicionales. Esta innovación promete condiciones de crecimiento optimizadas, tiempos de procesamiento más rápidos, una mayor previsibilidad de rendimiento y un consumo reducido de recursos. El mercado estadounidense de hongos funcionales y psicodélicos alcanzó 3,6 mil millones de dólares en 2022, con una tasa de crecimiento anual compuesta (CAGR) esperada del 12,1% desde 2023 hasta 2030.
하이파 랩스 (OTCQB:FUNI)가 주거용 미세균 생산을 위한 AI 기반의 혁신적인 방법 및 장치에 대한 새로운 특허 출원을 USPTO에 제출했습니다. 이 회사는 8일 성장 주기 안에 고품질 기능성 버섯 재료를 생산하기 위한 최초의 소비자 장치를 출시할 계획이며, 일반적으로 판매되는 버섯보다 더 정밀한 효능을 제공하고 현재 시장 가격의 일부에 해당하는 가격으로 제공합니다.
특허는 미세균 처리를 위한 정교한 기계 학습 알고리즘을 포함하며, 전통적인 재배 방법의 문제를 다룹니다. 이 혁신은 최적화된 성장 조건, 더 빠른 처리 시간, 향상된 수익 예측 가능성 및 자원 소비 절감을 약속합니다. 미국 기능성 및 환각 버섯 시장은 2022년에 36억 달러에 이르렀으며, 2023년부터 2030년까지 연평균 성장률(CAGR)이 12.1%로 예상됩니다.
Hypha Labs (OTCQB:FUNI) a déposé de nouvelles demandes de brevet auprès de l'USPTO pour des méthodes et dispositifs novateurs pilotés par IA pour la production de mycélium à domicile. L'entreprise vise à introduire le premier appareil de consommation pour produire des ingrédients de champignons fonctionnels de haute qualité dans un cycle de croissance de 8 jours, offrant une précision de puissance supérieure à celle des champignons vendus couramment, à une fraction des prix du marché actuel.
Les brevets couvrent des algorithmes d'apprentissage automatique sophistiqués pour le traitement du mycélium, abordant ainsi les défis des méthodes de culture traditionnelles. Cette innovation promet des conditions de croissance optimisées, des temps de traitement plus rapides, une meilleure prévisibilité des rendements et une consommation réduite de ressources. Le marché américain des champignons fonctionnels et psychédéliques a atteint 3,6 milliards de dollars en 2022, avec un taux de croissance annuel composé (CAGR) attendu de 12,1 % de 2023 à 2030.
Hypha Labs (OTCQB:FUNI) hat beim USPTO neue Patentanmeldungen für innovative KI-gestützte Methoden und Geräte zur In-Haus-Produktion von Myzel eingereicht. Das Unternehmen plant, das erste Verbrauchergerät zur Produktion von hochwertigen funktionalen Pilzzutaten in einem 8-tägigen Wachstumszyklus einzuführen, das eine genauere Wirksamkeit bietet als üblicherweise verkaufte Pilze und dies zu einem Bruchteil der aktuellen Marktpreise.
Die Patente umfassen ausgereifte maschinelle Lernalgorithmen zur Verarbeitung von Myzel und gehen auf Herausforderungen der traditionellen Anbaumethoden ein. Diese Innovation verspricht optimierte Wachstumsbedingungen, schnellere Verarbeitungszeiten, verbesserte ErtragVorhersagen und einen reduzierten Ressourcenverbrauch. Der US-Markt für funktionale und psychedelische Pilze erreichte 2022 einen Wert von 3,6 Milliarden USD, mit einer erwarteten jährlichen Wachstumsrate (CAGR) von 12,1% von 2023 bis 2030.
- Filing of new patent applications for AI-driven in-home mycelium production methods and devices
- Potential to revolutionize functional mushroom ingredient production with 8-day grow cycles and higher potency precision
- Addressing challenges in traditional mycelium processing with advanced machine learning algorithms
- Expanding into a rapidly growing market valued at $3.6 billion in 2022 with 12.1% CAGR
- Patent applications are pending and not yet approved
- Potential competition in the functional mushroom market
Company Intends to Bring First Functional Mushroom Producer to Retail
LAS VEGAS, NV / ACCESSWIRE / October 7, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the addition of significant mycological innovations to its current patent portfolio. The expanded patent portfolio now includes several filings with the United States Patent and Trademark Office (USPTO) that seek to protect a series of novel methods and devices designed to revolutionize the extraction of active components from mycelium and to create high-quality functional mushroom ingredients.
Functional Mushroom ingredients grown in the form of MicroPearls in Hypha Labs' Mushroom Accelerator
Hypha Laboratories is intent on bringing the first fully in-home device that will allow a consumer to produce their own mushroom-based ingredients in a grow cycle of approximately eight days and with greater potency precision than commonly sold mushrooms and mushroom ingredients. These home grown functional mushroom ingredients would be produced at a fraction of current market prices and in the privacy of a residence using the Company's patented and elegant mushroom accelerator instead of less desirable substrates such as animal waste.
In 2022, the U.S. market for functional and psychedelic mushrooms reached a valuation of USD
The pending patents seek to protect the use of sophisticated machine learning algorithms to process mycelium, the vegetative part of fungi composed of an intricate network of hyphae. The Company believes that this has tremendous potential across various sectors including pharmaceuticals, nutraceuticals, and biotechnology. Traditionally, mycelium processing has faced challenges due to prolonged cultivation times and the necessity of soil-based mushroom growth over extended durations. To address these issues, Hypha Labs has introduced groundbreaking Artificial Intelligence (AI) with novel machine learning methods that overcome these barriers, providing a more efficient and sustainable way to process mycelium for cultivating a broad array of functional mushroom ingredients. The integration of advanced machine learning offers significant advantages, including optimized growth conditions, accelerated processing times, enhanced yield predictability, and reduced resource consumption, thus potentially revolutionizing the mycelium and functional mushroom industry.
About Hypha Labs, Inc.
The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at HyphaLabs.com.
SAFE HARBOR FORWARD-LOOKING STATEMENTS:
This press release may contain forward-looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:
LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/
Twitter: https://x.com/Hypha_Labs
For more information about Hypha Labs visit HyphaLabs.com
For the Company's current Investor Presentation please visit www.HyphaLabs.com/deck
Investor and Media Relations:
Integrity Media Inc.
(888) 216-3595
team@integritymedia.com
Contact Information
Kurt Divich
President, Integrity Media Inc.
team@integritymedia.com
(888) 216-3595
SOURCE: Hypha Labs
View the original press release on accesswire.com
FAQ
What new patents has Hypha Labs (FUNI) filed?
How long is the grow cycle for Hypha Labs' (FUNI) proposed in-home mushroom production device?
What is the current valuation of the U.S. functional and psychedelic mushroom market according to Hypha Labs' (FUNI) press release?
What is the expected CAGR for the functional and psychedelic mushroom market from 2023 to 2030, as mentioned in Hypha Labs' (FUNI) announcement?
